for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

Spain's Almirall to buy U.S. dermatology portfolio from Allergan

Aug 3 (Reuters) - Spanish pharmaceutical company Almirall SA said on Friday it has agreed to buy a portfolio of five brands from U.S. firm Allergan for up to $650 million in cash.

Almirall said it would pay $550 million in cash upfront and that there is a possibility of an earn-out of up to $100 million based on business performance.

Reporting by Katarzyna Zajaczkowska in Gdynia; editing by Jason Neely

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up